The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How weight loss drugs actually work, and how big-name prescriptions differ ...

Mounting competition in the sector and rising obesity have led the pharmaceutical company to start selling the drug directly ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

Drinking artificially sweetened beverages may reduce metformin’s effectiveness in young patients with obesity and prediabetes ...

When her mother suggested she try a weight-loss drug ... If the group not taking the drug had benefited from the more intensive coaching, he believes the comparison would be fairer.

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide ...

Eli Lilly stock surges past $840, outperforming the S&P 500. Click here to learn why LLY stock is still undervalued and why now might be the time to invest.

Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock from hold to strong buy.

Learn more about how generics compare ... a drug for a purpose other than what it’s approved for. For instance, Rybelsus and Ozempic can be prescribed off-label for weight loss.

David Soliman, center, started a telehealth company after weight loss medication quieted "food noise" that had made it hard for him to lose weight. (Photo by Chris Granger, The Times-Picayune ...